title: [Erythropoiesis disorders and other central autoimmune anemias].
abstract: Immune-mediated acquired disorders of erythropoiesis can result in pure red cell aplasia or ineffective erythropoiesis. Erythropoiesis can be suppressed or impaired by humoral or cellular mechanisms. In vitro inhibition of erythroid colony growth by humoral factors or lymphocytes is a strong argument for the immune origin of the disease. Classical aetiologies are thymoma and hematological malignancies such as chronic lymphocytic leukaemia. Clonal proliferation of T cells has also been incriminated. Recently, acquired circulating autoantibodies directed against erythropoietin have been detected in a case of pure red cell aplasia. Autoimmune mechanisms have also been suggested in two dyserythropoietic syndromes recently described.
authors.affiliation: Laboratoire d'hématologie biologique L'Hôtel-Dieu 75181 Paris. nicole.casadevall@htd.ap-hop-paris.fr
authors.forename: N
authors.initials: N
authors.lastname: Casadevall
authors.forename: L
authors.initials: L
authors.lastname: Croisille
mesh_terms: D000740:Anemia / Q000276:immunology* / Q000503:physiopathology; D001327:Autoimmune Diseases / Q000276:immunology* / Q000473:pathology; D002455:Cell Division; D004920:Erythropoiesis / Q000276:immunology*; D004921:Erythropoietin / Q000276:immunology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000503:physiopathology; D012010:Red-Cell Aplasia, Pure / Q000276:immunology* / Q000503:physiopathology; D013601:T-Lymphocytes / Q000276:immunology; D013945:Thymoma / Q000503:physiopathology
chemical_list: D004921:Erythropoietin